Brief: Jaguar Health Inc's Unit Napo Pharmaceuticals Entered Into An Amended And Restated License Agreement
20/07/2022 22:24
July 20 (Reuters) - Jaguar Health Inc JAGX.O :
* JAGUAR HEALTH INC - ON JULY 19, UNIT NAPO PHARMACEUTICALS
ENTERED INTO AN AMENDED AND RESTATED LICENSE AGREEMENT
* JAGUAR HEALTH INC - AMENDED LICENSE AGREEMENT MODIFIES,
NAPO
THERA'S RIGHTS TO MANUFACTURE FINISHED PRODUCTS FOR CERTAIN
LICENSED INDICATIONS
* JAGUAR HEALTH - NAPO THERA WILL STILL BE ENTITLED TO
UTILIZE
ITS LICENSE TO MANUFACTURE PRODUCTS FOR LICENSED INDICATIONS
OTHER THAN IFD INDICATIONS
Further company coverage: JAGX.O
((Reuters.Briefs@thomsonreuters.com;))